XML 28 R17.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets
9 Months Ended
Sep. 30, 2024
Goodwill and Intangible Assets  
Goodwill and Intangible Assets

Note 10. Goodwill and Intangible Assets

Goodwill

The following table represents the changes in the carrying value of goodwill as of September 30, 2024 and December 31, 2023 (in thousands):

September 30, 

December 31, 

    

2024

    

2023

Balance at beginning of period

Goodwill

$

157,972

$

151,117

Accumulated impairment losses

(49,569)

Subtotal

108,403

151,117

Activity during the period

Foreign currency adjustment

16

(284)

Goodwill impairment charge

(54,563)

(49,569)

Goodwill related to Tec4med acquisition

 

 

2,694

Goodwill related to Bluebird Express acquisition

201

4,445

Balance at end of period

Goodwill

158,189

157,972

Accumulated impairment losses

(104,132)

(49,569)

Total

$

54,057

$

108,403

Impairment of Goodwill

Due to a sustained decrease in the Company’s share price in the second quarter of 2024, and a reduction in the projected operating performance of the MVE reporting unit, which management deemed to be triggering events related to goodwill and indefinite-lived intangible assets, we performed an interim impairment assessment of goodwill for the MVE and CRYOPDP reporting units as of June 30, 2024, with the assistance of an independent third party valuation specialist, using management’s updated interim financial and operational plans. Based on our analysis, we concluded that there has been no impairment of the goodwill associated with the CRYOPDP reporting unit as its carrying value did not exceed its estimated fair value. We further concluded that our MVE reporting unit’s carrying value exceeded its estimated fair value, and as a result, we recorded an impairment charge of $54.6 million related to full impairment of the goodwill related to the MVE reporting unit in the consolidated statement of operations for the six months ended June 30, 2024 and nine months ended September 30, 2024.

Our goodwill impairment test was performed using a combination of both an income and a market approach to determine the fair value of the MVE reporting unit. The income approach utilized the estimated discounted cash flows for MVE while the market approach utilized comparable peer group information. Estimates and assumptions used in the income approach included projected cash flows for MVE and a discount rate determined using a weighted average cost of capital for risk factors specific to MVE and other market and industry data. The discount rate selected was 12.5%. The other key estimates and assumptions used in the discounted cash flow method include, but are not limited to, revenue and EBITDA growth rates, and a terminal growth rate. The estimates and assumptions used in our assessment represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value.

Intangible Assets

The following table presents our intangible assets as of September 30, 2024 (in thousands):

Weighted

Net

Average

Gross

Accumulated

Carrying

Amortization

    

Amount

    

Amortization

    

Impairment

    

Amount

    

Period (years)

Non-compete agreement

$

810

$

463

$

$

347

 

4

Technology

53,316

14,602

38,714

8

Customer relationships

131,785

37,065

94,720

10

Trade name/trademark

947

323

(265)

359

8

Agent network

14,020

11,025

2,995

3

Order backlog

2,600

2,600

Land use rights

2,198

215

1,983

34

Patents and trademarks

45,762

85

(8,980)

36,697

Total

$

251,438

$

66,378

$

(9,245)

$

175,815

The following table presents our intangible assets as of December 31, 2023 (in thousands):

Weighted

Net

Average

Gross

Accumulated

Carrying

Amortization

    

Amount

    

Amortization

    

Amount

    

Period (years)

Non-compete agreement

$

810

$

368

$

442

 

5

Technology

50,376

11,205

39,171

9

Customer relationships

131,578

29,964

101,614

11

Trade name/trademark

938

211

727

10

Agent network

13,761

8,148

5,613

3

Order backlog

2,600

2,600

Land use rights

2,255

247

2,008

34

Patents and trademarks

44,932

125

44,807

 

Total

$

247,250

$

52,868

$

194,382

Amortization expense for intangible assets for the three and nine months ended September 30, 2024, was $4.3 million and $13.0 million, respectively. Amortization expense for intangible assets for the three and nine months ended September 30, 2023 was $4.0 million and $11.7 million, respectively.

Impairment of Trademarks and Trade Names

As part of our interim impairment assessment as of June 30, 2024 described further above, we recorded a $9.0 million impairment charge related to trademarks for our MVE reporting unit, and a $0.3 million impairment charge related to the write-off of Cell&Co’s trade name that is no longer in use as a result of the Company’s global rebranding initiative.

Expected future amortization of intangible assets as of September 30, 2024 is as follows:

Years Ending December 31, 

    

Amount

Remainder of 2024 (excluding the nine months ended September 30, 2024)

$

3,898

2025

 

15,124

2026

 

14,831

2027

 

14,450

2028

 

13,406

Thereafter

 

70,961

$

132,670